CytomX Therapeutics Inc (CTMX) is near the middle in its sector according to InvestorsObserver.
CTMX gets an overall rating of 14. That means it scores higher than 14% of stocks.
CytomX Therapeutics Inc gets a 44 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 14 means the stock is more attractive than 14 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease.
These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With CytomX Therapeutics Inc Stock Today?
CytomX Therapeutics Inc (CTMX) stock is up 3.76% while the S&P 500 is down -0.26% as of 11:51 AM on Monday, Jan 25. CTMX is higher by $0.25 from the previous closing price of $6.65 on volume of 765,534 shares. Over the past year the S&P 500 has risen 18.12% while CTMX is down -4.56%. CTMX lost -$1.17 per share the over the last 12 months.
Click Here to get the full Stock Score Report on CytomX Therapeutics Inc (CTMX) Stock.
